Understanding how pharmaceutical companies in the OSD sector are addressing Quality Control challenges
Scope of Study
Mid-February 24: Survey Launch
The world’s largest Quality Control barometer for the OSD drug product industry is launched to gain market insights and understand how pharmaceutical companies are addressing today’s QC challenges in batch, as well as continuous manufacturing.
February – May 24: Data Collection
Data are collected through the online questionnaire distributed via our partners, emailings, and social media.
May – October 24: Focus Group discussions
After 3 months of collection, the data will be consolidated in a first report, which will be discussed in focus groups involving industry experts. The experts invited will have the opportunity to discuss and compare the results with their own experience.
November 24: 2024 Report release
The Barometer’s questionnaire is aimed exclusively at decision-makers in the Oral Solid Dosage drug product manufacturing industry. It is mainly intended for:
- PAT Scientists / PAT Engineers
- Head of Manufacturing
- Process Managers
- Technical Launch Integrators
- …
- About the Questionnaire
The questionnaire is a dynamic form with skip logic in answers. Conditional instructions direct respondents to skip certain questions based on their previous answers, which enhances survey efficiency and relevance.
Questions with radio buttons (circles) require a single answer, while questions with checkboxes allow various answers. It takes approximately 10 minutes to answer all the questions.
- About Data Protection
We will ask you for personal information in order to contact or identify you. For deeper understanding and analysis, your data may be shared with our trusted partners who have signed a non-disclosure agreement.
However, the study results will be presented anonymously in a final report, available for download, ensuring confidentiality and privacy.
To know more, read our Privacy Policy.
The 2024 Quality Control Barometer is an independent study aiming to get a better insight into the current QC status in the OSD drug product manufacturing, including challenges, existing procedures, and future requirements.
With the current emergence of continuous manufacturing and the associated introduction of innovative technologies, there is a need for a different, improved approach to Quality Control.
Within this context, the 2024 QC Barometer has been initiated to collect data through an online questionnaire and better understand how companies are responding to current industry challenges and reacting to new trends, such as Process Analytical Technologies (PATs), paving the way for real-time release testing.
Study results will be anonymously published in a final report due in December 2024. It will enable companies from the OSD pharmaceutical industry to position themselves against other industry players and ultimately make better-informed decisions about their Quality Control Strategy.
Interested in shaping the
future of Quality Control?
Initiated by
Our partners
